Webinar | How Will Microbiome Reshape Anti-Aging Skin Care in 2026 Register Here

Arisaph Pharmaceuticals

Arisaph Pharmaceuticals is focused on the development of therapies for cancer, cardiovascular disease, and diabetes.
1999
11-50
Boston, Massachusetts, United States

Investment Funding

Last Funding Stage

Venture - Series Unknown

Total Funding Amount

10.M

Last Funding Amount

10.M

Last Funding Date

01-11-2013

Revenue

$1M to $10M

People

Founders

Something missing or incorrect on this page? Help us enrich this information